811 material Form 8-K filings that 685 companies we cover made with the SEC in April 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Directors Ramesh Gopalakrishnan and Jeffrey S. McCreary told the board they will not seek re-election at the 2025 annual meeting, citing no disagreement with the company. The board has nominated Glynis A. Bryan, retired CFO of Insight Enterprises, for election at that meeting, which matters to shareholders as a change in board composition.
Gopalakrishnan notified the board on April 2, 2025; McCreary on April 3, 2025
Both decided not to stand for re-election at the annual meeting on May 14, 2025, upon expiration of their terms
The filing states the decisions were not due to any disagreement with the company or board
Board nominated Glynis A. Bryan, retired CFO of Insight Enterprises, per the proxy statement filed April 4, 2025
On March 31, 2025, Tutor Perini signed Separation Benefits Agreements with three executives: Ghassan Ariqat, Kristiyan Assouri and CFO Ryan Soroka. The agreements set severance at 150% of base salary plus target bonus, rising to 200% if termination follows a change in control, and provide for equity vesting and a pro-rata bonus. The filing describes these as compensation terms for executives rather than a change in leadership, so the direct effect on shareholders is limited to the potential cost of severance if an executive leaves.
Agreements dated March 31, 2025, cover Ghassan M. Ariqat, Kristiyan D. Assouri and Ryan J. Soroka
Severance equals 150% of base salary plus target bonus, or 200% if termination occurs within two years after, or in some cases six months before, a change in control
Benefits include a pro-rata bonus based on actual performance and full vesting of equity awards, with performance awards vesting at the greater of target or actual performance
Payments are conditional on signing and not revoking a general release of claims
Effective March 31, 2025, CVR Energy appointed Robert E. Flint and Colin Kwak to its board, with Flint named chairperson, and Ted Papapostolou resigned from the board and its committees for personal reasons. Both new directors are employed by Icahn Enterprises or its affiliates, which indirectly owns approximately 68% of the company's common stock, so the change adds IEP-affiliated representation to the board that already reflects that controlling stake.
Robert E. Flint appointed to the board and named Chairperson, and to the Special Committee, effective March 31, 2025
Colin Kwak appointed to the board, the Compensation Committee, and the Nominating and Corporate Governance Committee, effective March 31, 2025
Ted Papapostolou resigned from the board and its committees effective March 31, 2025, citing personal reasons
Board size increased from seven to eight directors; IEP owns approximately 68% of outstanding common stock
MP Materials appointed David G. Infuso, a longtime company accounting executive, as Chief Accounting Officer and principal accounting officer effective April 4, 2025. CFO Ryan Corbett, who previously held the principal accounting officer role, remains Chief Financial Officer and principal financial officer, so the change is administrative and does not alter the company's financial leadership.
Infuso, 41, joined MP Materials in November 2020 and was most recently Senior Vice President of Financial Reporting and Technical Accounting
Base salary of $315,000 under an employment agreement effective April 4, 2025, plus a discretionary bonus
Grant of 9,932 restricted stock units dated April 1, 2025, vesting in four equal annual installments
Ryan Corbett continues as Chief Financial Officer and principal financial officer
Sunrun director Manjula Talreja resigned from the board and from its Audit and Nominating, Governance, and Sustainability committees, effective April 4, 2025. The filing says the resignation was not due to any disagreement with the company, and the board cut its size from nine to eight directors. The change is administrative and does not involve financial results or guidance.
Talreja notified her resignation on April 1, 2025; it takes effect April 4, 2025.
She had served on the board since January 2022, the Audit Committee since April 2022, and the NGS Committee since February 2024.
The filing states the resignation was not due to any disagreement with the company, the board or management.
Board size was reduced from nine to eight directors, effective April 4, 2025.
OneSpaWorld Holdings said Chief Commercial Officer Susan Bonner is leaving, effective immediately, with the departure announced March 17, 2025. On April 1, 2025, the company and Ms. Bonner agreed to severance terms treated as a termination without cause, including 24 months of continued base salary instead of the 12 months in her employment agreement, conditional on compliance with restrictive covenants.
Susan Bonner departed as Chief Commercial Officer, effective immediately; departure announced March 17, 2025
Agreement reached April 1, 2025 provides 24 months of continued base salary, up from 12 months under her employment agreement
Equity awards (restricted and performance stock units) treated as provided under her agreement for a termination without cause, subject to restrictive covenant compliance
Cintas said Chief Financial Officer Mike Hansen will retire from the CFO role and become Assistant to the CEO effective May 31, 2025. Scott Garula, President of the Rental Division, was appointed to succeed him as Executive Vice President and CFO effective June 1, 2025, a planned transition the company describes as following a succession process.
Mike Hansen retires as Executive Vice President and CFO; he notified the company on March 31, 2025, and moves to Assistant to the CEO effective May 31, 2025
Scott Garula, 54, was appointed on April 1, 2025 as Executive Vice President and CFO effective June 1, 2025; he joined Cintas in 1996 and was President and COO of the Rental Division from June 2023
Garula's initial annual pay: $650,000 base salary, 90% of base salary target annual incentive, and $1,500,000 target long-term incentive
One-time promotion awards under the 2016 Equity Plan: restricted stock with $250,000 and non-qualified stock options with $75,000 grant date fair value
Neurocrine Biosciences said Sanjay Keswani, M.D., will succeed Eiry W. Roberts, M.D., as Chief Medical Officer effective June 2, 2025. Dr. Roberts, who has held the role for seven years, will remain with the company in a strategic advisory role. The change replaces a long-serving clinical leader with an executive who has more than 20 years of pharmaceutical industry experience.
Sanjay Keswani, M.D., agreed on April 2, 2025 to become Chief Medical Officer, effective June 2, 2025
Dr. Keswani succeeds Eiry W. Roberts, M.D., who has served as CMO for the past seven years
Dr. Roberts previously announced her retirement in July 2023 and will stay on in a strategic advisory role
Dr. Keswani was previously President and CEO of ImmunoBrain and held R&D roles at Hoffmann-La Roche and Bristol-Myers Squibb
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.